Top gainers and losers, Aug 31: Adani Ent falls 10%, Adani Ports declines 7%, Sun Pharma rises 3%; check list

Prime gainers and losers: The Indian benchmark indices, SENSEX and NIFTY50, closed in unfavorable territory on Monday, August 31, amid a sell-off in media and steel shares and a surge in crude oil costs as Iran and the US traded assaults for the primary time in additional than a month, elevating fears of a renewed battle after weeks of relative navy calm.

Open FREE Demat Account inside minutes!

Join now

Moreover, investor sentiment was additionally impacted by international funding outflows, MSCI’s current rebalancing transfer, and weak international cues.

On Friday, international institutional traders (FIIs) offered shares value ₹5,039.80 crore, whereas home institutional traders (DIIs) bought shares value ₹5,183.93 crore on a web foundation, in accordance with alternate knowledge.

The SENSEX declined as a lot as 0.66% to hit an intraday low of 76,751.32. In the meantime, the NIFTY50 tumbled as a lot as 0.75% to the touch the session’s low of 23,993.60.

On August 31, the 30-share BSE SENSEX slumped 307.23 factors or 0.40% to shut at 76,957.27. The 50-share NIFTY fell by 95.25 factors or 0.39% to finish at 24,080.40.

NIFTY50 prime gainers and losers

Adani Enterprises (-9.76%), Adani Ports & SEZ (-6.70%), ITC Ltd (-3.95%), Bharti Airtel (-3.75%), and Tata Motors PV (-3.30%) had been among the many prime losers.

Shares of Adani Enterprises and Adani Ports declined amid a decline within the broader market and heightened volatility forward of the MSCI index reshuffle. In keeping with a Reuters report, Adani Enterprises and Adani Ports are more likely to obtain inflows of about $202 million and $77 million, respectively. Adani Power Options can also be anticipated to see inflows of round $310 million. READ MORE.

However, the highest gainers included Solar Pharmaceutical Industries (3.38%), Nestle India (2.88%), Axis Financial institution (2.77%), Max Healthcare Institute (2.76%) and Grasim Industries (2.46%).

NIFTY Midcap 100 prime gainers and losers

NSE’s NIFTY midcap gauge, the Midcap 100, ended 0.24% or 155.25 factors larger at 64,224.75 on August 31.

The index was supported by Aurobindo Pharma, which closed 4.36% larger, because the wholly owned subsidiary of Aurobindo Pharma USA, Inc., Lannett Firm LLC, launched the generic equal of Advair Diskus (fluticasone propionate and salmeterol inhalation powder), a product of GSK plc, in 100/50 mcg and 250/50 mcg strengths, within the US market.

It was adopted by Lenskart Options (4.22%), FSN E-Commerce Ventures (4.14%), One 97 Communications (4.01%) and Polycab India (3.93%), which had been among the many different prime winners.

On the flip aspect, Persistent Techniques (-4.77%), GMR Airports (-4.76%), KPIT Applied sciences (-4%), BSE (-3.61%) and Nationwide Aluminium Firm (-3.41%) had been among the many prime laggards.

NIFTY Smallcap 100 prime gainers and losers

The NIFTY Smallcap 100 closed at 19,931.65, down by 148.35 factors or 0.74%.

The highest losers had been Kaynes Know-how India (-6.55%), Wockhardt (-4.66%), Jyoti CNC Automation (-4.18%), Nuvama Wealth Administration (-3.26%) and Chambal Fertilizers & Chemical substances (-3.21%).

Quite the opposite, the highest gainers included Ather Power (6.27%), Ola Electrical Mobility (4.93%), Metropolis Union Financial institution (3.27%), Pc Age Administration Providers (2.62%), and Brigade Enterprises (2.51%).

Shares of Ather Power hit a 52-week excessive on Monday, August 31, as traders reacted to a sequence of launches together with the Bedrock battery pack, the mass-market e-scooter Konarc, larger vary choices for current product traces, and a number of other new options. READ MORE.

On Saturday, August 29, Ather launched its new EV scooter named Konarc at a worth of ₹99,999 ex-showroom in Bengaluru, in an effort to focus on a bigger viewers base and appeal to extra prospects amid elevated competitors available in the market.

The corporate has launched the automobile in three variants, specifically, S100, S125 and S160, with plans to ship the S125 and S160 variants ranging from mid-September 2026.


Disclaimer: This text is written purely for informational functions and shouldn’t be thought of funding recommendation from Upstox. Securities talked about are illustrative and never suggestions. Please seek the advice of a monetary advisor earlier than making any funding choices.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *